HomeNewsIndiaAll protocols for setting up of BSL-3 lab completed in Nagaland, waiting for ICMR nod: Kesonyu Yhome

All protocols for setting up of BSL-3 lab completed in Nagaland, waiting for ICMR nod: Kesonyu Yhome

All measures including infrastructure and human resource training were completed for the BSL-3 set up at NHAK here while the testing of the lab was conducted on Tuesday, said Health and Family Welfare secretary Kesonyu Yhome.

May 12, 2020 / 20:48 IST
Story continues below Advertisement

The Nagaland Health and Family Welfare department has completed all protocols for setting up of the Bio-Safety Laboratory (BSL-3) for testing of COVID-19 samples at the Naga Hospital Authority Kohima (NHAK), an official said on Tuesday.

All measures including infrastructure and human resource training were completed for the BSL-3 set up at NHAK here while the testing of the lab was conducted on Tuesday, said Health and Family Welfare secretary Kesonyu Yhome.

Story continues below Advertisement

Coronavirus India News LIVE Updates

All measures have been carefully completed and sent to Indian Council of Medical Research (ICMR) New Delhi, he said, adding that the department is waiting on further updates on the functionality of the laboratory.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show